Bill
Bill > S05022
NY S05022
NY S05022Prohibits a health care plan from making prescription drug formulary changes during a contract year.
summary
Introduced
03/06/2017
03/06/2017
In Committee
01/03/2018
01/03/2018
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
2017-2018 General Assembly
Bill Summary
AN ACT to amend the insurance law and the public health law, in relation to prescription drug formulary changes during a contract year The People of the State of New York, represented in Senate and Assem- bly, do enact as follows: 1
AI Summary
This bill prohibits health care plans from making certain changes to prescription drug formularies during a contract year, such as removing drugs, moving drugs to a tier with higher cost-sharing, or adding utilization management restrictions. The bill provides exceptions for when a generic equivalent or interchangeable biological product is added, or when the FDA determines a drug should be removed from the market. The bill also requires plans to provide notice to policyholders of any formulary or cost-sharing changes for the upcoming plan year prior to the open enrollment period.
Committee Categories
Business and Industry
Sponsors (35)
Susan Serino (R)*,
Joe Addabbo (D),
Fred Akshar (R),
Marisol Alcantara (OTHER),
Tony Avella (D),
John Bonacic (R),
Neil Breslin (D),
John Brooks (D),
David Carlucci (D),
Leroy Comrie (D),
Thomas Croci (R),
John DeFrancisco (R),
Martin Golden (R),
Joe Griffo (R),
Jesse Hamilton (D),
Kemp Hannon (R),
Pam Helming (R),
Christopher Jacobs (R),
Todd Kaminsky (D),
Timothy Kennedy (D),
Liz Krueger (D),
Andrew Lanza (R),
Kenneth LaValle (R),
Kathleen Marchione (R),
Shelley Mayer (D),
Terrence Murphy (R),
Rob Ortt (R),
Kevin Parker (D),
Patricia Ritchie (R),
Gustavo Rivera (D),
Joseph Robach (R),
James Sanders (D),
Diane Savino (D),
Luis Sepúlveda (D),
David Valesky (OTHER),
Last Action
PRINT NUMBER 5022C (on 04/17/2018)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...